$EXEL2025 · v5
Exelixis (EXEL): 13.4x EV/EBITDA and 14.6x EV/FCF Price a Mature Franchise Despite 35.0% ROIC and 33.2% FCF Growth
Interesting research candidate
67Signal score
2025Fiscal year
HealthcareSector
67Interesting research candidate
Research PDF
signalshield-EXEL-2025-v5.pdf
⬇ Download full PDFDirect download. Opens in any PDF reader. Public archive report.
This report is provided for informational research support only. It does not constitute investment, financial, or trading advice.
← All research reports